Mucosal Immunity in Cystic Fibrosis

Area of Science:

• Immunology
• Genetics
• Pulmonology

Background:

• Cystic Fibrosis (CF) exhibits complex genotype-phenotype relationships linked to the CF transmembrane conductance regulator (CFTR) gene.
• Chronic lung infections and excessive immune responses are primary causes of morbidity and mortality in CF.
• Current CFTR modulator therapies do not fully resolve inflammation and persistent infections.

Purpose of the Study:

• To review recent advances in understanding the innate and adaptive immune systems in CF lung disease.
• To highlight the role of immune genes in the pulmonary phenotype of CF.
• To underscore the need for further research into mucosal immunity in CF.

Main Methods:

• Literature review of recent advances in CF immunology.
• Analysis of gene modifier studies implicating immune genes in CF pulmonary disease.
• Synthesis of current knowledge on host immune responses in CF.

Main Results:

• Immune gene modifiers significantly influence the pulmonary phenotype in CF.
• Both innate and adaptive immune systems are excessively and ineffectively activated in CF lungs.
• Persistent inflammation and bacterial infections occur despite CFTR-targeted therapies.

Conclusions:

• Further research into mucosal immunity determinants is essential for CF.
• A deeper understanding of immune system dysregulation is needed for improved CF therapies.
• Immune system modulation may offer novel therapeutic strategies for CF lung disease.